We are live on ! Find out more
CFO

Callan Family Office Portfolio holdings

AUM $4.41B
1-Year Est. Return 26.21%
This Fund
S&P 500
This Quarter Est. Return
-1.19%
1 Year Est. Return
+26.21%
3 Year Est. Return
+68.96%
5 Year Est. Return
10 Year Est. Return
AUM
$1.33B
AUM Growth
-$239M
Cap. Flow
-$202M
Cap. Flow %
-15.12%
Top 10 Hldgs %
30.52%
Holding
657
New
30
Increased
136
Reduced
341
Closed
114

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$20M
2
AAPL icon
Apple
AAPL
+$19.1M
3
NVDA icon
NVIDIA
NVDA
+$18.1M
4
AMZN icon
Amazon
AMZN
+$14.7M
5
COST icon
Costco
COST
+$8.84M

Sector Composition

Rank Sector Weight
1 Technology 17.08%
2 Financials 12.66%
3 Healthcare 9.69%
4 Communication Services 6.06%
5 Consumer Discretionary 5.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LHX icon
301
L3Harris
LHX
$54.1B
$569K 0.04%
2,719
-2,335
-46% -$489K
MCK icon
302
McKesson
MCK
$103B
$567K 0.04%
842
+35
+4% +$21.6K
ANET icon
303
Arista Networks
ANET
$241B
$565K 0.04%
7,290
-1,836
-20% -$186K
NVMI
304
Nova
NVMI
$12.3B
$565K 0.04%
3,064
-40
-1% -$9.24K
ETR icon
305
Entergy
ETR
$49.3B
$564K 0.04%
6,592
-6,326
-49% -$521K
SAN icon
306
Banco Santander
SAN
$209B
$563K 0.04%
84,043
-111,423
-57% -$652K
PEG icon
307
Public Service Enterprise Group
PEG
$37.2B
$553K 0.04%
6,718
-1,198
-15% -$100K
AON icon
308
Aon
AON
$75.5B
$547K 0.04%
1,371
-39
-3% -$15K
GM icon
309
General Motors
GM
$77.7B
$541K 0.04%
11,510
+1,258
+12% +$62K
FCN icon
310
FTI Consulting
FCN
$4.18B
$539K 0.04%
3,288
-6,162
-65% -$1.11M
KKR icon
311
KKR & Co
KKR
$93.5B
$535K 0.04%
4,631
+2,634
+132% +$362K
AIG icon
312
American International
AIG
$40.6B
$534K 0.04%
6,143
-2,257
-27% -$175K
PFE icon
313
Pfizer
PFE
$154B
$530K 0.04%
20,934
-1,480
-7% -$38.7K
MFC icon
314
Manulife Financial
MFC
$73.3B
$515K 0.04%
16,526
-12,514
-43% -$378K
ELAN icon
315
Elanco Animal Health
ELAN
$11.2B
$515K 0.04%
49,024
+12,304
+34% +$139K
LSTR icon
316
Landstar System
LSTR
$6.12B
$509K 0.04%
3,392
-2,188
-39% -$353K
SCI icon
317
Service Corp International
SCI
$11.3B
$505K 0.04%
6,302
-9,180
-59% -$722K
DXCM icon
318
DexCom
DXCM
$33.2B
$505K 0.04%
7,389
+4,328
+141% +$353K
CNC icon
319
Centene
CNC
$32.8B
$502K 0.04%
8,266
-9,410
-53% -$569K
BMY icon
320
Bristol-Myers Squibb
BMY
$133B
$496K 0.04%
8,134
-3,505
-30% -$204K
FMS icon
321
Fresenius Medical Care
FMS
$12.9B
$495K 0.04%
19,898
-2,285
-10% -$54.4K
WRB icon
322
W.R. Berkley
WRB
$26.2B
$491K 0.04%
6,898
-12,694
-65% -$778K
WELL icon
323
Welltower
WELL
$169B
$490K 0.04%
3,200
-895
-22% -$128K
IJT icon
324
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.37B
$490K 0.04%
3,935
URI icon
325
United Rentals
URI
$70.9B
$489K 0.04%
781
-343
-31% -$236K

Similar funds

Callan Family Office's Q1 2025 Portfolio in Review

As of Q1 2025, Callan Family Office held 657 positions worth $1.33B, down 15% from $1.57B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Callan Family Office withdrew a net $202M in Q1 2025, closing 114 positions and reducing 341 holdings. Its most notable exit was iShares MSCI ACWI ex US ETF, an estimated $3.63M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Callan Family Office opened a new position in Berkshire Hathaway Class A worth $4.79M.

  • Callan Family Office's largest Q1 2025 buy was Berkshire Hathaway Class A: 6 shares worth $4.79M.
  • Callan Family Office added most to iShares Core S&P 500 ETF in Q1 2025, an estimated $5.25M increase.
  • Callan Family Office's biggest Q1 2025 reduction was Microsoft, cutting an estimated $20M.
  • Callan Family Office fully exited iShares MSCI ACWI ex US ETF in Q1 2025, selling an estimated $3.63M.
  • Callan Family Office's ten largest holdings make up 31% of its $1.33B portfolio in Q1 2025.
  • Callan Family Office opened 30 new positions and closed 114 in Q1 2025.
  • Callan Family Office's portfolio value fell 15% quarter-over-quarter to $1.33B.

Based on Callan Family Office's 13F filing for Q1 2025, filed 13 May 2025.